The CX3CL1-CX3CR1 signaling axis, formed by a ligand–receptor interaction between transmembrane CX3CL1 and its cognate receptor, modulates malignant phenotypes encompassing proliferation, migration, invasion, and apoptosis resistance in cancer, suggesting its therapeutic relevance (36). This evidence concerns the gene CX3CL1 and cancer.